Euclidean Capital as of Dec. 31, 2021
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 11 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pmv Pharmaceuticals (PMVP) | 30.7 | $54M | 2.3M | 23.10 | |
| Foghorn Therapeutics (FHTX) | 16.4 | $29M | 1.3M | 22.87 | |
| Alector (ALEC) | 11.5 | $20M | 981k | 20.65 | |
| Tenaya Therapeutics (TNYA) | 9.9 | $17M | 916k | 18.95 | |
| Rapt Therapeutics | 9.0 | $16M | 433k | 36.73 | |
| Ngm Biopharmaceuticals | 7.5 | $13M | 747k | 17.71 | |
| Oric Pharmaceuticals (ORIC) | 6.2 | $11M | 748k | 14.70 | |
| Surrozen | 2.9 | $5.2M | 803k | 6.44 | |
| Marqeta Class A Com (MQ) | 2.4 | $4.3M | 248k | 17.17 | |
| First Financial Ban (FFBC) | 2.4 | $4.2M | 174k | 24.38 | |
| Vir Biotechnology (VIR) | 1.0 | $1.7M | 40k | 41.88 |
